220 related articles for article (PubMed ID: 34575893)
1. Plant Viral Nanoparticle Conjugated with Anti-PD-1 Peptide for Ovarian Cancer Immunotherapy.
Gautam A; Beiss V; Wang C; Wang L; Steinmetz NF
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575893
[TBL] [Abstract][Full Text] [Related]
2. Cowpea Mosaic Virus Nanoparticles and Empty Virus-Like Particles Show Distinct but Overlapping Immunostimulatory Properties.
Wang C; Beiss V; Steinmetz NF
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375592
[TBL] [Abstract][Full Text] [Related]
3. Antibody Response against Cowpea Mosaic Viral Nanoparticles Improves
Shukla S; Wang C; Beiss V; Steinmetz NF
ACS Nano; 2020 Mar; 14(3):2994-3003. PubMed ID: 32133838
[TBL] [Abstract][Full Text] [Related]
4. Inactivated Cowpea Mosaic Virus in Combination with OX40 Agonist Primes Potent Antitumor Immunity in a Bilateral Melanoma Mouse Model.
Koellhoffer EC; Mao C; Beiss V; Wang L; Fiering SN; Boone CE; Steinmetz NF
Mol Pharm; 2022 Feb; 19(2):592-601. PubMed ID: 34978197
[TBL] [Abstract][Full Text] [Related]
5. Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy.
Beiss V; Mao C; Fiering SN; Steinmetz NF
Mol Pharm; 2022 May; 19(5):1573-1585. PubMed ID: 35333531
[TBL] [Abstract][Full Text] [Related]
6. In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma.
Murray AA; Wang C; Fiering S; Steinmetz NF
Mol Pharm; 2018 Sep; 15(9):3700-3716. PubMed ID: 29798673
[TBL] [Abstract][Full Text] [Related]
7. The unique potency of Cowpea mosaic virus (CPMV)
Shukla S; Wang C; Beiss V; Cai H; Washington T; Murray AA; Gong X; Zhao Z; Masarapu H; Zlotnick A; Fiering S; Steinmetz NF
Biomater Sci; 2020 Sep; 8(19):5489-5503. PubMed ID: 32914796
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Fate of Cowpea Mosaic Virus In Situ Vaccine: Biodistribution and Clearance.
Affonso de Oliveira JF; Chan SK; Omole AO; Agrawal V; Steinmetz NF
ACS Nano; 2022 Nov; 16(11):18315-18328. PubMed ID: 36264973
[TBL] [Abstract][Full Text] [Related]
9. In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade.
Mao C; Beiss V; Ho GW; Fields J; Steinmetz NF; Fiering S
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36460333
[TBL] [Abstract][Full Text] [Related]
10. The Potency of Cowpea Mosaic Virus Particles for Cancer In Situ Vaccination Is Unaffected by the Specific Encapsidated Viral RNA.
Jung E; Chung YH; Mao C; Fiering SN; Steinmetz NF
Mol Pharm; 2023 Jul; 20(7):3589-3597. PubMed ID: 37294891
[TBL] [Abstract][Full Text] [Related]
11. CD47 Blockade and Cowpea Mosaic Virus Nanoparticle In Situ Vaccination Triggers Phagocytosis and Tumor Killing.
Wang C; Steinmetz NF
Adv Healthc Mater; 2019 Apr; 8(8):e1801288. PubMed ID: 30838815
[TBL] [Abstract][Full Text] [Related]
12. Injectable Hydrogel Containing Cowpea Mosaic Virus Nanoparticles Prevents Colon Cancer Growth.
Nkanga CI; Steinmetz NF
ACS Biomater Sci Eng; 2022 Jun; 8(6):2518-2525. PubMed ID: 35522951
[TBL] [Abstract][Full Text] [Related]
13. In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer.
Lizotte PH; Wen AM; Sheen MR; Fields J; Rojanasopondist P; Steinmetz NF; Fiering S
Nat Nanotechnol; 2016 Mar; 11(3):295-303. PubMed ID: 26689376
[TBL] [Abstract][Full Text] [Related]
14. A Combination of Cowpea Mosaic Virus and Immune Checkpoint Therapy Synergistically Improves Therapeutic Efficacy in Three Tumor Models.
Wang C; Steinmetz NF
Adv Funct Mater; 2020 Jul; 30(27):. PubMed ID: 34366758
[TBL] [Abstract][Full Text] [Related]
15. Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade.
Karan S; Jung E; Boone C; Steinmetz NF
Cancer Immunol Immunother; 2024 Feb; 73(3):51. PubMed ID: 38349406
[TBL] [Abstract][Full Text] [Related]
16. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
[TBL] [Abstract][Full Text] [Related]
17. Cowpea Mosaic Virus and Natural Killer Cell Agonism for In Situ Cancer Vaccination.
Koellhoffer EC; Steinmetz NF
Nano Lett; 2022 Jul; 22(13):5348-5356. PubMed ID: 35713326
[TBL] [Abstract][Full Text] [Related]
18. Combination of Plant Virus Nanoparticle-Based in Situ Vaccination with Chemotherapy Potentiates Antitumor Response.
Lee KL; Murray AA; Le DHT; Sheen MR; Shukla S; Commandeur U; Fiering S; Steinmetz NF
Nano Lett; 2017 Jul; 17(7):4019-4028. PubMed ID: 28650644
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer.
McGray AJR; Huang RY; Battaglia S; Eppolito C; Miliotto A; Stephenson KB; Lugade AA; Webster G; Lichty BD; Seshadri M; Kozbor D; Odunsi K
J Immunother Cancer; 2019 Jul; 7(1):189. PubMed ID: 31315674
[TBL] [Abstract][Full Text] [Related]
20. Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors.
Mao C; Beiss V; Fields J; Steinmetz NF; Fiering S
Biomaterials; 2021 Aug; 275():120914. PubMed ID: 34126409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]